Breast Reconstruction Flap Salvage
FDA-cleared application: venous decompression of compromised DIEP, TRAM, and latissimus dorsi flaps in post-mastectomy reconstruction.
Patient Summary
- Is this FDA-cleared for this use?
- Yes — FDA-cleared under K040187 (June 21, 2004) for medicinal leech application to relieve venous congestion in microsurgical reconstructive procedures, including breast reconstruction flaps.
- What evidence exists?
- This is an FDA-cleared use. The largest published hospital series (Nguyen 2012, n=154) reports that about 78 percent of congested DIEP flaps were saved when leech therapy was added to surgical re-exploration. Major U.S. cancer centers (MD Anderson, Memorial Sloan Kettering, Mayo) include leech availability in their post-operative protocols. Leeches do not replace surgery — if the issue is an artery problem or a fixable surgical clot, the surgical team must address that first.
- Main risks
- Bleeding from each bite site for 6 to 10 hours after the leech detaches
- Need for blood transfusion (about 1 in 3 patients) from cumulative blood loss over the treatment course
- Aeromonas hydrophila infection (your team starts an antibiotic such as ciprofloxacin before the first leech)
- Loss of the flap despite treatment if the underlying artery problem cannot be fixed
- Allergic reaction to leech saliva (uncommon)
- Visible bite-mark scarring on the reconstructed breast that may fade but may not disappear entirely
- Longer hospital stay and emotional stress from a complication after an already long surgery
- Who should not consider this
- Patients on warfarin, apixaban, rivaroxaban, dabigatran, or heparin
- Patients with hemophilia or another inherited bleeding disorder
- Patients with severe anemia (hemoglobin under 10 g/dL) before therapy
- Patients with active bloodstream infection or sepsis
- Patients allergic to ciprofloxacin and other antibiotics covering Aeromonas
- Patients whose flap has completely died (no salvage is possible — surgical removal is needed)
- Patients whose flap problem is an artery issue (this requires surgical revision, not leeches)
- What to ask your clinician
- Is this an artery problem, a vein problem, or both? Leeches only help with vein problems.
- Should I be taken back to the operating room before or instead of starting leech therapy?
- Which antibiotic will I get for Aeromonas prevention, and for how long?
- How often will my blood count be checked, and at what level would you transfuse?
- How will the bite scars look once everything heals, and is there anything that helps them fade?
- If the flap fails despite leeches, what are my options — a new flap from a different site, an implant, or no reconstruction?
- Will my breast cancer follow-up care be affected by this complication or by the transfusions?
- When to seek urgent care
- Bleeding from any bite site soaking through more than one dressing per hour, or bleeding lasting more than 24 hours after the leech detaches
- Increasing redness, warmth, swelling, or pus around the flap or bite sites
- Fever above 38.0 C / 100.4 F, chills, or feeling suddenly unwell
- Flap turning darker, colder, or harder despite leech therapy
- Hives, swelling of the face or tongue, or any breathing difficulty
What this does NOT mean
- It does not mean the flap is guaranteed to survive — about 20 to 40 percent of severely congested flaps are still lost, especially when the artery is the real problem.
- It does not mean leeches replace surgical re-exploration — for early problems (less than 6 hours after surgery) the team will usually take you back to the operating room first.
- It does not mean home use is safe — this is hospital therapy with antibiotics and blood-count monitoring.
- It does not affect your cancer outcome — leech therapy is for the reconstruction, not the cancer treatment.
Safety cross-references
Clinical Profile
- Category
- surgical reconstruction
- ICD-10
- T86.821, T87.41, N64.89, Z90.13
- Safety tier
- high
Evidence Summary
Free flap breast reconstruction (DIEP, TRAM, SIEA, PAP, latissimus) has a venous compromise rate of 3-7%. Early identification (within hours) and prompt leech application can support flap salvage in a substantial fraction of cases that would otherwise progress toward total flap loss. Evidence is drawn from mixed-flap experience rather than breast-specific trials: a 2012 systematic review of 277 reported clinical cases of leech therapy across plastic and reconstructive surgery found an overall success (salvage) rate of about 78%, while a 2012 retrospective series of 39 patients with venous congestion found that among 27 regional and free flaps roughly one-third were fully salvaged, one-third partially salvaged, and one-third lost. Routine institutional protocols at major reconstructive centers include leech availability in the postoperative pathway. Leech therapy does not replace surgical re-exploration for arterial issues or for early venous compromise where revision of the anastomosis is feasible.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Nguyen MQ et al. (2012), n=39 · PMID 22473683 · ASH analysis →
- Knobloch K et al. (2007)0 · PMID 17497605 · ASH analysis →
- Whitaker IS et al. (2012), n=277 · PMID 22407551 · ASH analysis →
- Cohort: 1 (33%)
- Systematic Review: 2 (67%)
Detailed Trial Entries
6 trials indexed in the ASH RCT Library with full Study Profile, GRADE rating, and clinical implications:
- Leech (Hirudo medicinalis) Therapy for the Treatment of Nipple-Areolar Complex Congestion Following Breast Reduction
Freeman M, Carney M, Matatov T, Vemula R, Babycos C (2015) · Eplasty · n=1 · GRADE very-low
- Compromised breast flap treated with leech therapy, hyperbaric oxygen, pentoxifylline and topical nitroglycerin: A case report
Moffat AD, Weaver LK, Tettelbach WH (2015) · Undersea & Hyperbaric Medicine · n=1 · GRADE very-low
- Infection following Leech Therapy for the Treatment of Nipple-Areola Complex Congestion after Breast Reduction: A Case Report
Torresetti M, Peltristo B, Taddei FMJ, Di Benedetto G (2024) · Archives of Plastic Surgery · n=1 · GRADE very-low
- The Use of Medicinal Leeching in Breast Surgery: A Systematic Review
Rajaram R, Cevik J, Bhindi N, Seth I, Rozen WM (2024) · Journal of Clinical Medicine · n=28 · GRADE low
- Early venous congestion after DIEP flap breast reconstruction: case report of a successful management
Baccarani A, Starnoni M, Pappalardo M, Lattanzi M, Blessent CGF, De Maria F, De Santis G (2022) · Acta Biomedica · n=1 · GRADE very-low
- Infections following the application of leeches: two case reports and review of the literature
Maetz B, Abbou R, Andreoletti JB, Bruant-Rodier C (2012) · Journal of Medical Case Reports · n=2 · GRADE very-low
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Total flap necrosis (non-salvageable; proceed to debridement)
- Arterial insufficiency (must address surgically before leeching)
Related Conditions
Venous Congestion in Surgical Flaps
FDA-cleared application: medicinal leech therapy to relieve venous congestion in compromised tissue flaps awaiting vascular ingrowth.
Microsurgical Replantation (Digit / Ear / Scalp)
FDA-cleared application: post-replantation venous decompression in digits, ears, scalp, and partial avulsion injuries.